Xebra Brands Ltd. (XBRAF) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Xebra Brands Ltd. (XBRAF) trades at $0.0001. Xebra Brands Ltd. is a Canadian cannabis company focused on developing and distributing cannabis-infused beverages and wellness products. Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for XBRAF: XBRAF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates XBRAF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
Not enough scored data yet to form a council read on XBRAF.
How is this calculated? →Xebra Brands Ltd. (XBRAF) Healthcare & Pipeline Overview
Xebra Brands Ltd. cultivates, processes, manufactures, and distributes cannabis products in Canada, focusing on cannabis-infused beverages and wellness products. Operating under brands like HighJack and MadCap, Xebra targets the evolving Canadian cannabis market amidst increasing competition and regulatory changes, with a current market capitalization of $0.00B.
What Is the Investment Thesis for XBRAF?
Xebra Brands Ltd. operates in the high-growth Canadian cannabis market, with a focus on cannabis-infused beverages and wellness products. Key value drivers include the expansion of its branded product lines (HighJack, MadCap) and penetration into new Canadian markets. The company's negative profit margin of -1831.8% and gross margin of -288.6% indicate significant challenges in achieving profitability. Growth catalysts include potential regulatory changes favoring cannabis-infused products and successful product innovation. However, the company faces risks related to intense competition, regulatory uncertainties, and the need for substantial capital to scale operations. Investors should closely monitor Xebra's ability to improve its financial performance and gain market share in the competitive cannabis industry.
Based on FMP financials and quantitative analysis
XBRAF Key Highlights
Market Cap of $0.00B reflects the company's current valuation in the market.
- P/E Ratio of -0.14 indicates the company is currently not profitable.
- Profit Margin of -1831.8% highlights significant challenges in achieving profitability.
- Gross Margin of -288.6% suggests substantial costs associated with producing and selling its products.
- Beta of -1.90 indicates the stock price is negatively correlated with the market, potentially offering diversification benefits.
Who Are XBRAF's Competitors?
XBRAF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| INNPF INNOCAN PHARMA Corp | $1.60 | -8.05% | $7.20M | 61 |
| GENH Generation Hemp, Inc. | $0.22 | +0.00% | $25.3M | 63 |
| GBLP Global Pharmatech, Inc. | $0.08 | +0.00% | $33.3M | 62 |
| ETST Earth Science Tech, Inc. | $0.12 | +14.45% | $35.3M | 61 |
| GDNSF Goodness Growth Holdings, Inc. | $0.45 | +0.00% | $61.1M | 64 |
| MNNGF Baijin Life Science Holdings Limited | $0.08 | +0.00% | $74.6M | 63 |
| SHIEF Shield Therapeutics plc | $0.07 | +0.00% | $75.3M | 62 |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109M | 66 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are XBRAF's Key Strengths?
Established brands in the cannabis beverage market.
- Diverse product portfolio including beverages and wellness products.
- Operations in the rapidly growing Canadian cannabis market.
- Expertise in cannabis cultivation, processing, and manufacturing.
What Are XBRAF's Weaknesses?
Negative profit margin and gross margin.
- Limited market share compared to larger competitors.
- Dependence on regulatory approvals and changes.
- Need for significant capital investment to scale operations.
What Could Drive XBRAF Stock Higher?
Potential regulatory changes in Canada favoring cannabis-infused beverages.
- Expansion of distribution network into new Canadian provinces.
- Development and launch of new cannabis-based wellness products.
What Are the Key Risks for XBRAF?
Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Intense competition from established cannabis companies.
- Regulatory uncertainties and changes in the Canadian cannabis market.
- Fluctuations in cannabis prices and demand.
- Negative profit margin and gross margin impacting financial sustainability.
What Are the Growth Opportunities for XBRAF?
- Expansion of Cannabis-Infused Beverage Line: Xebra Brands has the opportunity to expand its line of cannabis-infused beverages, targeting the growing demand for alternative consumption methods. The Canadian cannabis beverage market is projected to reach $500 million by 2028. By introducing new flavors, formulations, and product formats, Xebra can attract a wider customer base and increase its market share. This expansion requires investment in research and development, marketing, and distribution partnerships, with potential for significant revenue growth within the next 3-5 years.
- Penetration of New Canadian Markets: Xebra Brands can expand its geographic reach within Canada by entering new provincial markets. Each province has its own regulatory framework and distribution channels, requiring a tailored market entry strategy. Successful penetration of new markets can significantly increase Xebra's revenue and brand recognition. This expansion requires careful planning, regulatory compliance, and investment in distribution infrastructure, with potential for incremental revenue growth in the next 2-4 years.
- Development of Innovative Wellness Products: Xebra Brands can capitalize on the growing demand for cannabis-based wellness products by developing innovative formulations and delivery methods. The wellness market includes products such as capsules, tinctures, topicals, and intimate oils. By focusing on product differentiation and scientific validation, Xebra can attract health-conscious consumers and establish a strong position in the wellness market. This requires investment in research and development, clinical trials, and marketing, with potential for long-term revenue growth.
- Strategic Partnerships and Acquisitions: Xebra Brands can pursue strategic partnerships and acquisitions to expand its product portfolio, market reach, and operational capabilities. Collaborating with other cannabis companies, beverage manufacturers, or wellness brands can provide access to new technologies, distribution channels, and customer segments. Acquisitions can provide synergies and economies of scale, enhancing Xebra's competitive position. This requires careful due diligence, negotiation, and integration, with potential for significant value creation.
- Focus on Brand Building and Marketing: Xebra Brands can invest in brand building and marketing to increase brand awareness, customer loyalty, and market share. Effective marketing campaigns can highlight the unique attributes of Xebra's products, differentiate them from competitors, and attract target customers. Brand building requires a consistent message, engaging content, and effective use of social media and other marketing channels. This can lead to increased sales, customer retention, and brand equity over the long term.
What Are XBRAF's Competitive Advantages?
- Brand recognition through established brands like HighJack and MadCap.
- Proprietary formulations for cannabis-infused beverages and wellness products.
- Established distribution network in select Canadian markets.
- Expertise in cannabis cultivation, processing, and manufacturing.
What Does XBRAF Do?
Xebra Brands Ltd., established in 2019 and headquartered in Vancouver, Canada, is a cannabis company focused on the cultivation, processing, manufacturing, design, and delivery of cannabis products. The company's primary focus is on cannabis-infused beverages, including seltzers, soft drinks, iced teas, lemonades, waters, and energy and sport drinks. Additionally, Xebra Brands offers wellness products such as capsules, tinctures, topicals, and intimate oils for personal care. Xebra Brands operates under several brands, including HighJack, MadCap, Vicious Citrus, Conquer, HolaHi, and HighCastle. These brands cater to different consumer preferences and market segments within the cannabis industry. The company aims to establish a strong presence in the Canadian cannabis market by offering a diverse product portfolio and focusing on innovation and quality. Since its inception, Xebra Brands has been navigating the evolving regulatory landscape of the Canadian cannabis industry. The company's strategy involves developing and marketing products that comply with Canadian regulations while meeting consumer demand for innovative cannabis products. Xebra Brands faces competition from established players in the cannabis industry, as well as new entrants, requiring a focus on brand differentiation and efficient operations to succeed.
What Products and Services Does XBRAF Offer?
- Cultivates cannabis plants.
- Processes raw cannabis into various forms.
- Manufactures cannabis-infused beverages.
- Produces cannabis wellness products like capsules and tinctures.
- Designs product packaging and branding.
- Distributes cannabis products to retailers in Canada.
How Does XBRAF Make Money?
- Cultivation and processing of cannabis.
- Manufacturing and distribution of branded cannabis products.
- Sales through retail channels and partnerships.
- Revenue generation from product sales.
What Industry Does XBRAF Operate In?
Xebra Brands operates within the Canadian cannabis industry, which is experiencing rapid growth and evolving regulatory frameworks. The market includes both recreational and medicinal cannabis products, with increasing demand for cannabis-infused beverages and wellness products. Competition is intense, with numerous companies vying for market share. Key trends include product innovation, regulatory changes, and increasing consumer acceptance of cannabis. Xebra Brands must navigate these trends and competitive pressures to establish a sustainable market position.
Who Are XBRAF's Key Customers?
- Recreational cannabis consumers in Canada.
- Wellness-focused individuals seeking cannabis-based products.
- Retailers and distributors of cannabis products.
- Consumers interested in cannabis-infused beverages.
Company Profile
Xebra Brands Ltd. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Vancouver, CA. The company is led by CEO Rodrigo Valencia Gallardo. XBRAF has traded publicly since 2021.
Financial Health
Xebra Brands Ltd.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
XBRAF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- Established brands in the cannabis beverage market.
- Diverse product portfolio including beverages and wellness products.
- Operations in the rapidly growing Canadian cannabis market.
- Expertise in cannabis cultivation, processing, and manufacturing.
Bear Case
- Negative profit margin and gross margin.
- Limited market share compared to larger competitors.
- Dependence on regulatory approvals and changes.
- Need for significant capital investment to scale operations.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
XBRAF Latest News
No recent news available for XBRAF.
XBRAF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for XBRAF.
Price Targets
Wall Street price target analysis for XBRAF.
XBRAF MoonshotScore
What does this score mean?
The MoonshotScore rates XBRAF 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Rodrigo Valencia Gallardo
CEO
Rodrigo Valencia Gallardo is the Chief Executive Officer of Xebra Brands Ltd. His background includes experience in business development, strategic planning, and operations management. He has held various leadership positions in the consumer goods and cannabis industries. His expertise lies in driving growth, building strong teams, and executing strategic initiatives. He is responsible for overseeing all aspects of Xebra Brands' operations, including cultivation, processing, manufacturing, and distribution.
Track Record: Under Rodrigo Valencia Gallardo's leadership, Xebra Brands has focused on expanding its product portfolio and market presence in the Canadian cannabis market. Key milestones include the launch of new cannabis-infused beverage brands and the development of innovative wellness products. He has also focused on building strategic partnerships and strengthening the company's distribution network. His leadership is aimed at positioning Xebra Brands for long-term growth and success in the competitive cannabis industry.
XBRAF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Xebra Brands Ltd. may not meet the minimum financial standards or reporting requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and operational performance compared to companies listed on major exchanges like the NYSE or NASDAQ. This tier often includes companies with higher risk profiles and speculative ventures.
- OTC Tier: OTC Other
- Limited financial disclosure and transparency.
- Lower liquidity and potential for price volatility.
- Higher risk of fraud or mismanagement.
- Potential for delisting or trading suspension.
- Limited regulatory oversight compared to major exchanges.
- Verify the company's financial reporting status and access available financial statements.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Review any available independent research reports or analyst opinions.
- Check for any regulatory filings or legal proceedings.
- Monitor trading volume and price volatility.
- Understand the risks associated with investing in OTC stocks.
- Established brands in the cannabis beverage market.
- Operations in the rapidly growing Canadian cannabis market.
- Experienced management team with industry expertise.
- Focus on regulatory compliance and product quality.
- Partnerships with reputable distributors and retailers.
What Investors Ask About Xebra Brands Ltd. (XBRAF) — Healthcare
What does Xebra Brands Ltd. do?
Xebra Brands Ltd. is a Canadian cannabis company focused on the cultivation, processing, manufacturing, and distribution of cannabis products. The company specializes in cannabis-infused beverages, including seltzers, soft drinks, and iced teas, as well as wellness products like capsules, tinctures, and topicals.
What do analysts say about XBRAF stock?
As of 2026-03-17, there is no readily available analyst consensus on XBRAF stock due to its OTC listing and limited coverage. Key valuation metrics such as the P/E ratio (-0.14) and negative profit margin (-1831.8%) indicate that the company is currently not profitable.
What are the main risks for XBRAF?
The main risks for XBRAF include intense competition in the Canadian cannabis market, regulatory uncertainties and changes, fluctuations in cannabis prices and demand, and the company's negative profit margin and gross margin. As an OTC-listed company, XBRAF also faces risks related to limited financial disclosure, lower liquidity, and potential for price volatility. Investors should carefully consider these risks before investing in XBRAF stock.
What are the key factors to evaluate for XBRAF?
Evaluate XBRAF on fundamentals, analyst consensus, and risk factors. Xebra Brands Ltd. operates in the high-growth Canadian cannabis market, with a focus on cannabis-infused beverages and wellness products. Not financial advice.
How frequently does XBRAF data refresh on this page?
XBRAF's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven XBRAF's recent stock price performance?
Xebra Brands Ltd. (XBRAF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established brands in the cannabis beverage market. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider XBRAF overvalued or undervalued right now?
Xebra Brands Ltd. (XBRAF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research XBRAF before investing?
Before investing in Xebra Brands Ltd. (XBRAF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- OTC market data may be limited or inconsistent.